Table 2.
Adverse event | Safety analysis population (n=33) |
||
---|---|---|---|
Total | Grade 1/2 | Grade 3/4 | |
Most common adverse events (≥ 20%) | |||
Fever | 13 (39.3) | 9/3 (36.3) | 1/1 (6.0) |
Neutrophil count decreased | 10 (30.3) | 3/7 (30.3) | |
Peripheral sensory neuropathy | 9 (27.3) | 8/1 (27.3) | |
Fatigue | 8 (24.2) | 2/3 (15.1) | 3/0 (9.1) |
Nausea | 7 (21.2) | 2/3 (15.1) | 2/0 (6.0) |
Platelet count decreased | 7 (21.2) | 1/0 (3.0) | 2/4 (18.2) |
Abdominal pain | 7 (21.2) | 2/3 (15.1) | 2/0 (6.0) |
Common adverse events (≥ 10%) | |||
Diarrhea | 6 (18.1) | 3/3 (18.1) | - |
Vomiting | 6 (18.1) | 2/3 (15.1) | 1/0 (3.0) |
Anorexia | 6 (18.1) | 2/3 (15.1) | 1/0 (3.0) |
Edema (facial, periorbital, or leg) | 5 (15.1) | 2/2 (12.1) | 1/0 (3.0) |
Myalgia | 5 (15.1) | 2/3 (15.1) | - |
Skin rash | 5 (15.1) | 2/2 (12.1) | 1/0 (3.0) |
Anemia | 4 (12.1) | 0/1 (3.0) | 3/0 (9.1) |
Rhinosinusitis | 4 (12.1) | 0/3 (9.1) | 1/0 (3.0) |
Upper respiratory infection | 4 (12.1) | 2/2 (12.1) | - |
ALT/AST increased | 4 (12.1) | 2/0 (6.0) | 1/1 (6.0) |
Pruritus | 4 (12.1) | 2/2 (12.1) | - |
Less common events (≥ 5%) | |||
Dyspnea | 3 (9.0) | 1/1 (6.0) | 1/0 (3.0) |
Sore throat | 3 (9.0) | 1/2 (9.0) | - |
Cough | 3 (9.0) | 1/2 (9.0) | - |
Febrile neutropenia | 2 (6.0) | 2/0 (6.0) | |
Abdominal distension | 2 (6.0) | 1/1 (6.0) | - |
Oral mucositis | 2 (6.0) | 1/0 (3.0) | 1/0 (3.0) |
Herpes zoster | 2 (6.0) | 1/1 (6.0) | - |
Creatinine increased | 2 (6.0) | 1/1 (6.0) | - |
Back pain | 2 (6.0) | 0/1 (3.0) | 1/0 (3.0) |
Neck pain | 2 (6.0) | 1/1 (6.0) | - |
Dizziness | 2 (6.0) | 1/1 (6.0) | - |
Headache | 2 (6.0) | 1/1 (6.0) | - |
Urinary frequency | 2 (6.0) | 1/1 (6.0) | - |
Laryngospasm | 2 (6.0) | 0/2 (6.0) | - |
Anxiety/Depressive mood | 2 (6.0) | 2/0 (6.0) | |
Chest pain | 2 (6.0) | 1/0 (3.0) | 1/0 (3.0) |
Rare events (1 case reported) | |||
Constipation | 1 (3.0) | 0/1 (3.0) | |
Dyspepsia | 1 (3.0) | 0/1 (3.0) | |
Hemorrhoid bleeding | 1 (3.0) | 1/0 (3.0) | |
Perianal abscess | 1 (3.0) | 0/1 (3.0) | |
Gout | 1 (3.0) | 1/0 (3.0) | |
Urinary tract infection | 1 (3.0) | 1/0 (3.0) | |
Hypocalcemia | 1 (3.0) | 0/1 (3.0) | |
Stroke | 1 (3.0) | 1/0 (3.0) | |
Insomnia | 1 (3.0) | 0/1 (3.0) | |
Suicide attempt | 1 (3.0) | 0/1 (3.0) | |
Hoarseness | 1 (3.0) | 1/0 (3.0) | |
Pneumonia | 1 (3.0) | 1/0 (3.0) | |
Phlebitis | 1 (3.0) | 0/1 (3.0) |
Values are presented as number (%). ALT, alanine transaminase; AST, aspartate aminotransferase.